Evidence map›Paper›PMID 41294214›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Advancing Structure Elucidation with a Flexible Multi-Spectral AI Model.

Martin Priessner, Richard J Lewis, Isak Lemurell, Magnus J Johansson, JonathanM Goodman, Jon Paul Janet, Anna Tomberg

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Advancing Structure Elucidation with a Flexible Multi-Spectral AI Model.Angewandte Chemie (International ed. in English) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Martin PriessnerMedicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.ORCID https://orcid.org/0009-0005-7349-283X
Richard J LewisDepartment of Medicinal Chemistry, Research & Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.ORCID https://orcid.org/0000-0001-9404-8520
Isak LemurellMedicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.
Magnus J JohanssonMedicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.ORCID https://orcid.org/0000-0001-8811-2629
JonathanM GoodmanCentre for Molecular Informatics, Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.
Jon Paul JanetMolecular AI, Discovery Sciences, R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.ORCID https://orcid.org/0000-0001-7825-4797
Anna TombergMedicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.ORCID https://orcid.org/0000-0002-0718-5381

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Validating chemical synthesis success requires confirming the desired product using various analytical techniques. While spectroscopic data collection is increasingly automated, interpreting results remains a major bottleneck, often requiring expert input. With advances in laboratory automation and high-throughput synthesis, this challenge is expected to intensify. We introduce the MultiModalSpectralTransformer (MMST), a machine learning method that predicts chemical structures directly from diverse spectral data (NMR, IR, and MS). Trained on 4 million simulated compounds, MMST achieves 72% and 80% as top-1 and top-3 accuracy, respectively. To address out-of-distribution challenges, we implemented an active learning improvement cycle that generates molecules in similar chemical spaces, enabling the model to adapt to chemical structures beyond its original training data. We demonstrate MMST's capabilities through comprehensive benchmarking across diverse molecular weight ranges and chemical spaces. Notably, despite training solely on simulated data, MMST demonstrates good performance with experimental spectra. This research represents a significant advancement in automated structure elucidation, offering a powerful and adaptable tool that bridges the gap between simulated and real-world data.

Indexed as

Computer‐assisted structure elucidationIRMachine learningNMRTransformer

Identifiers

PMID41294214
PMCPMC12790320

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.